Cambridge, United States
Marengo Therapeutics: Marengo Therapeutics, a clinical stage biotech company, is pioneering an entirely new way to activate the body’s own immune system to mount a rapid, effective, and durable response against cancer. Their unique therapeutic platform selectively boosts T cells, turbocharging potent anti-tumor activity and promoting long-term immunity to keep cancer at bay.
Founded: 2015
Industries: Health Care
Headquarter: United States
Last Investment: $80.00M Series B investment at 08 November 2021
Last Investment Investors: Apple Tree Partners
Marengo Therapeutics, with its innovative approach to activating the immune system against cancer, has garnered significant attention in the biotech and healthcare industry. The recent $80.00M Series B investment from Apple Tree Partners further validates the promise and potential of Marengo's unique therapeutic platform. As a clinical stage company founded in 2015, Marengo Therapeutics continues to position itself at the forefront of the fight against cancer, offering a new frontier in immune cell activation. For more information, visit their website at marengotx.com.
